289 related articles for article (PubMed ID: 27419353)
21. The Hippo-YAP pathway: new connections between regulation of organ size and cancer.
Zhao B; Lei QY; Guan KL
Curr Opin Cell Biol; 2008 Dec; 20(6):638-46. PubMed ID: 18955139
[TBL] [Abstract][Full Text] [Related]
22. Regulation of the Hippo Pathway by Phosphatidic Acid-Mediated Lipid-Protein Interaction.
Han H; Qi R; Zhou JJ; Ta AP; Yang B; Nakaoka HJ; Seo G; Guan KL; Luo R; Wang W
Mol Cell; 2018 Oct; 72(2):328-340.e8. PubMed ID: 30293781
[TBL] [Abstract][Full Text] [Related]
23. The Hippo pathway in normal development and cancer.
Maugeri-Saccà M; De Maria R
Pharmacol Ther; 2018 Jun; 186():60-72. PubMed ID: 29305295
[TBL] [Abstract][Full Text] [Related]
24. Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence.
Ettinger SL; Sobel R; Whitmore TG; Akbari M; Bradley DR; Gleave ME; Nelson CC
Cancer Res; 2004 Mar; 64(6):2212-21. PubMed ID: 15026365
[TBL] [Abstract][Full Text] [Related]
25. Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway.
Toloczko A; Guo F; Yuen HF; Wen Q; Wood SA; Ong YS; Chan PY; Shaik AA; Gunaratne J; Dunne MJ; Hong W; Chan SW
Cancer Res; 2017 Sep; 77(18):4921-4933. PubMed ID: 28720576
[TBL] [Abstract][Full Text] [Related]
26. Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation.
Yu FX; Zhang Y; Park HW; Jewell JL; Chen Q; Deng Y; Pan D; Taylor SS; Lai ZC; Guan KL
Genes Dev; 2013 Jun; 27(11):1223-32. PubMed ID: 23752589
[TBL] [Abstract][Full Text] [Related]
27. Sphingolipid synthetic pathways are major regulators of lipid homeostasis.
Worgall TS
Adv Exp Med Biol; 2011; 721():139-48. PubMed ID: 21910087
[TBL] [Abstract][Full Text] [Related]
28. MEKK2 and MEKK3 orchestrate multiple signals to regulate Hippo pathway.
Lu J; Hu Z; Deng Y; Wu Q; Wu M; Song H
J Biol Chem; 2021; 296():100400. PubMed ID: 33571521
[TBL] [Abstract][Full Text] [Related]
29. WW and C2 domain-containing proteins regulate hepatic cell differentiation and tumorigenesis through the hippo signaling pathway.
Hermann A; Wennmann DO; Gromnitza S; Edeling M; Van Marck V; Sudol M; Schaefer L; Duning K; Weide T; Pavenstädt H; Kremerskothen J
Hepatology; 2018 Apr; 67(4):1546-1559. PubMed ID: 29116649
[TBL] [Abstract][Full Text] [Related]
30. The hippo signaling pathway in development and cancer.
Pan D
Dev Cell; 2010 Oct; 19(4):491-505. PubMed ID: 20951342
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation of LATS kinases alters p53 to promote cell migration.
Furth N; Bossel Ben-Moshe N; Pozniak Y; Porat Z; Geiger T; Domany E; Aylon Y; Oren M
Genes Dev; 2015 Nov; 29(22):2325-30. PubMed ID: 26588988
[TBL] [Abstract][Full Text] [Related]
32. The Hippo signaling pathway in liver regeneration and tumorigenesis.
Hong L; Cai Y; Jiang M; Zhou D; Chen L
Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):46-52. PubMed ID: 25476204
[TBL] [Abstract][Full Text] [Related]
33. Sterol regulatory element-binding proteins (SREBPs) as regulators of lipid metabolism: polyunsaturated fatty acids oppose cholesterol-mediated induction of SREBP-1 maturation.
Kim HJ; Miyazaki M; Man WC; Ntambi JM
Ann N Y Acad Sci; 2002 Jun; 967():34-42. PubMed ID: 12079833
[TBL] [Abstract][Full Text] [Related]
34. The Hippo Pathway Targets Rae1 to Regulate Mitosis and Organ Size and to Feed Back to Regulate Upstream Components Merlin, Hippo, and Warts.
Jahanshahi M; Hsiao K; Jenny A; Pfleger CM
PLoS Genet; 2016 Aug; 12(8):e1006198. PubMed ID: 27494403
[TBL] [Abstract][Full Text] [Related]
35. The Hippo-p53 pathway in megakaryopoiesis.
Suraneni PK; Crispino JD
Haematologica; 2016 Dec; 101(12):1446-1448. PubMed ID: 27903710
[No Abstract] [Full Text] [Related]
36. p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression.
Moon SH; Huang CH; Houlihan SL; Regunath K; Freed-Pastor WA; Morris JP; Tschaharganeh DF; Kastenhuber ER; Barsotti AM; Culp-Hill R; Xue W; Ho YJ; Baslan T; Li X; Mayle A; de Stanchina E; Zender L; Tong DR; D'Alessandro A; Lowe SW; Prives C
Cell; 2019 Jan; 176(3):564-580.e19. PubMed ID: 30580964
[TBL] [Abstract][Full Text] [Related]
37. A Non-Canonical Hippo Pathway Represses the Expression of ΔNp63.
Low-Calle AM; Ghoneima H; Ortega N; Cuibus AM; Katz C; Prives C; Prywes R
Mol Cell Biol; 2024 Jan; 44(1):27-42. PubMed ID: 38270135
[TBL] [Abstract][Full Text] [Related]
38. Integration of Hippo-YAP Signaling with Metabolism.
Ibar C; Irvine KD
Dev Cell; 2020 Jul; 54(2):256-267. PubMed ID: 32693058
[TBL] [Abstract][Full Text] [Related]
39. LncRNA MALAT1/miR-181a-5p affects the proliferation and adhesion of myeloma cells via regulation of Hippo-YAP signaling pathway.
Sun Y; Jiang T; Jia Y; Zou J; Wang X; Gu W
Cell Cycle; 2019 Oct; 18(19):2509-2523. PubMed ID: 31397203
[TBL] [Abstract][Full Text] [Related]
40. Control of Proliferation and Cancer Growth by the Hippo Signaling Pathway.
Ehmer U; Sage J
Mol Cancer Res; 2016 Feb; 14(2):127-40. PubMed ID: 26432795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
